U.S. Software Stock News

NYSE:AMC
NYSE:AMCEntertainment

AMC Entertainment Holdings (AMC) Posts Q4 Loss That Challenges Bullish Margin Narratives

AMC Entertainment Holdings (AMC) just posted its FY 2025 numbers with Q4 revenue of US$1,288.3 million, a basic EPS loss of US$0.25, and net income excluding extra items showing a loss of US$127.4 million, while trailing 12 month figures sit at US$4.8 billion of revenue, a basic EPS loss of US$1.34, and a net loss of US$632.4 million. Over recent quarters, the company has seen quarterly revenue move from US$862.5 million in Q1 2025 to between roughly US$1.3 billion and US$1.4 billion through...
NYSE:DINO
NYSE:DINOOil and Gas

Is HF Sinclair (DINO) Still Attractive After Recent Share Price Volatility?

If you are wondering whether HF Sinclair is still good value after its recent run, or if the price already reflects most of the story, this article will walk you through what the current share price could be implying. The stock recently closed at US$49.59, with a 7 day return of 15.3% decline, a 30 day return of 0.8% decline, a 1 year return of 41.1% and a 5 year return of 50.6%. These moves sit against a backdrop of ongoing interest in US energy stocks, where investors have been weighing...
NYSE:CTS
NYSE:CTSElectronic

Can CTS (CTS) Sustain Its Capital Returns While Pursuing an Acquisition-Driven Strategy?

CTS Corporation recently reported past full-year 2025 results showing higher sales and net income than the prior year, reaffirmed 2026 sales guidance of US$550 million–US$580 million, and declared a US$0.04 per-share cash dividend payable on April 24, 2026 to shareholders of record on March 27, 2025. Alongside these results, CTS highlighted strong cash generation, active share repurchases, and an intention to pursue acquisitions while continuing to return cash to shareholders. Next, we'll...
NasdaqGS:SBRA
NasdaqGS:SBRAHealth Care REITs

A Look At Sabra Health Care REIT (SBRA) Valuation After 2025 Results And 2026 Earnings Guidance

Earnings and guidance put Sabra Health Care REIT in focus Sabra Health Care REIT (SBRA) moved into the spotlight after reporting its fourth quarter and full year 2025 results, alongside issuing 2026 earnings guidance that outlines expected net income per diluted share. See our latest analysis for Sabra Health Care REIT. At a share price of $20.43, Sabra’s recent 1 month share price return of 8.55% and 1 year total shareholder return of 37.23% indicate that momentum has been building around...
NYSE:FG
NYSE:FGInsurance

Is F&G Annuities & Life (FG) Now A Potential Opportunity After Steep Share Price Slide

If you are wondering whether F&G Annuities & Life is quietly turning into a value opportunity or just looks cheap on the surface, it helps to step back from the headlines and focus on what the numbers actually say. The share price closed at US$23.32, with returns of an 18% decline over 7 days, a 16.4% decline over 30 days, a 22.4% decline year to date and a 41.5% decline over the past year, while the 3 year return sits at 20.4%. Recent news coverage has largely centered on the company as an...
NasdaqGS:CHTR
NasdaqGS:CHTRMedia

Is Charter Communications (CHTR) Pricing Misaligned After Sharp Multi Year Share Price Declines

If you are wondering whether Charter Communications' current share price reflects its true worth, you are not alone. This article focuses squarely on what the recent numbers might be telling you about value. The stock last closed at US$227.52, with a 30 day return of 18.7% and a 7 day return of 4.8% decline, set against a 1 year return of 37.8% decline, a 3 year return of 39.3% decline and a 5 year return of 63.3% decline. Recent price moves come against a backdrop of ongoing attention on...
NasdaqGM:APPN
NasdaqGM:APPNSoftware

Is It Time To Reassess Appian (APPN) After Its Multi Year Share Price Slide

If you are wondering whether Appian is starting to look interesting at its current share price, this breakdown will help you judge what you are really paying for. The stock closed at US$24.25, with a 6.0% gain over the last 7 days, but a 18.4% decline over 30 days and a 28.8% decline year to date, alongside a 27.0% decline over 1 year, 42.0% over 3 years and 87.0% over 5 years. These moves sit against a backdrop where Appian has continued to attract attention as a low code software platform,...
NasdaqGS:ULCC
NasdaqGS:ULCCAirlines

Why Frontier Group (ULCC) Is Down 8.8% After Swinging To Loss And Filing ESOP Share Shelf

Frontier Group Holdings, Inc. recently reported full-year 2025 results showing revenue of US$3,724 million and a swing from US$85 million net income to a US$137 million net loss, and later filed a US$12.25 million shelf registration for 2,290,108 common shares tied to its employee stock ownership plan. The combination of weaker profitability metrics and a new ESOP-related equity registration highlights how Frontier is balancing employee incentives with a more pressured financial...
NYSE:HTGC
NYSE:HTGCCapital Markets

Hercules Capital Directors Buy Shares As Credit Risks And Dividends Draw Focus

Multiple Hercules Capital (NYSE:HTGC) directors, including Thomas J. Fallon and Nikos Theodosopoulos, recently bought substantial amounts of company stock. The insider purchases come during a period of sector uncertainty tied to software exposure and payment in kind loans. These trades arrive shortly after a recent analyst downgrade and rising attention on the company's credit risk profile. For you as an investor, the timing of this insider buying stands out because it follows a stretch of...
NasdaqGS:CARG
NasdaqGS:CARGInteractive Media and Services

CarGurus Buyback Highlights Marketplace Focus And Questions On Future Margins

CarGurus, NasdaqGS:CARG, has authorized a new $250 million share repurchase program. The company is sharpening its focus on its core marketplace and international growth after winding down CarOffer. Management highlighted strong revenue, record retention, and faster dealer acquisition, including outside the US. CarGurus, trading at $27.86, sits at an interesting crossroads, with a 3-year return of 63.4% and a 5-year return of 5.5%. In the shorter term, the stock is down 18.1% over the past...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

Has Most Of The Easy Money In Wynn Resorts (WYNN) Already Been Made At US$107?

Wondering if Wynn Resorts at around US$107 is offering value today or if the easy money has already been made? This article is designed to help you frame that question clearly. The stock is down about 5.4% over the last week and 5.5% over the last month, yet it still shows a 20.1% return over the past year. That combination can change how you think about both upside potential and risk. Recent coverage has focused on Wynn Resorts as a major casino and resort operator with exposure to both...
NYSE:BOH
NYSE:BOHBanks

How CEO Retirement and Insider Sale Will Impact Bank of Hawaii’s (BOH) Leadership and Risk Narrative

Earlier in February 2026, Bank of Hawaii Corporation disclosed that Director Robert W. Wo Jr., through the Robert Ching Wo Trust 1985, sold 5,000 indirectly held common shares, while the bank also confirmed its CEO plans to retire at the end of March 2026. The combination of leadership transition and insider share sale has sharpened investor focus on how Bank of Hawaii will manage succession and governance continuity. We’ll now examine how the CEO’s planned retirement may influence Bank of...
NYSE:ROL
NYSE:ROLCommercial Services

Does Rollins’ M&A-Focused Strategy After Strong 2025 Results Reinforce Its Long-Term Narrative (ROL)?

Rollins, Inc. recently reported higher fourth-quarter and full-year 2025 earnings, continued to signal a healthy M&A pipeline, and earlier this month presented its outlook at Barclays’ 43rd Annual Industrial Select Conference in Miami. Management’s emphasis on recurring revenue, disciplined acquisitions, and confidence in funding further deals after investing almost US$900 million over three years highlights how central M&A has become to Rollins’ growth ambitions. We’ll now examine how...
NasdaqGS:THRM
NasdaqGS:THRMAuto Components

Gentherm (THRM) Valuation Check After Earnings Miss Record Revenue And New 2026 To 2027 Guidance

Gentherm (THRM) is back in focus after reporting fourth quarter and full year 2025 results that showed much lower net income alongside record revenue, along with new revenue guidance for 2026 and 2027. See our latest analysis for Gentherm. The latest results and 2026 to 2027 revenue guidance came as the share price closed at $32.51, with a 1 day share price return of 4.69% decline and a 1 year total shareholder return of 4.35% decline. This points to pressure on the Gentherm story after...
NasdaqGS:SBAC
NasdaqGS:SBACSpecialized REITs

Is SBA Communications (SBAC) Pricing Look Interesting After Recent Share Price Reset?

If you are wondering whether SBA Communications is attractively priced or still looks expensive at around US$199.64, starting with a clear view of its valuation can help you frame the opportunity and the risks. The stock has been relatively flat over the last week with a 0.6% decline, while the 30 day return sits at 6.7% and the 1 year return at a 4.3% decline. Some investors may see this as a reset after a 19.0% decline over 3 years and a 13.6% decline over 5 years. Recent coverage has...
NasdaqGS:SANA
NasdaqGS:SANABiotechs

Assessing Sana Biotechnology (SANA) Valuation After Recent Share Price Momentum

Sana Biotechnology (SANA) has been drawing attention after a mixed stretch in its share performance, with a small gain over the past week contrasting with a decline over the past month. See our latest analysis for Sana Biotechnology. At the current share price of $4.07, Sana Biotechnology has seen a 5.71% 7 day share price return and a 15.95% 90 day share price return. Its 1 year total shareholder return of 41.32% contrasts with a 5 year total shareholder return loss of 87.76%, suggesting...
NYSE:SCL
NYSE:SCLChemicals

Stepan (SCL) Thin 2% Margin And EPS Slide Reinforce Bearish Narratives In FY 2025

Stepan (SCL) has wrapped up FY 2025 with fourth quarter revenue of US$553.9 million and basic EPS of US$0.22, while trailing twelve month figures show revenue of about US$2.3 billion and EPS of US$2.05. Over recent periods, revenue has moved from US$546.8 million in Q3 2024 to the US$590.3 million to US$594.7 million range across the first three quarters of 2025, with quarterly EPS ranging from US$0.47 to US$0.86, and trailing EPS shifting between US$2.01 and US$2.54. With a trailing net...
NYSE:FET
NYSE:FETEnergy Services

Forum Energy Technologies (FET) Is Up 16.7% After Record Backlog And Buyback Completion - Has The Bull Case Changed?

In February 2026, Forum Energy Technologies reported that Q4 2025 sales were US$202.2 million with net income of US$2.07 million, while completing a US$35.00 million buyback of 1.40 million shares, or 11.68% of its stock, under the repurchase plan announced in December 2024. The company exited 2025 with a US$312.0 million order backlog, the largest in 11 years, and issued 2026 guidance calling for US$800.0–US$880.0 million in revenue, highlighting how improved earnings, a stronger order...
NYSE:CUBE
NYSE:CUBESpecialized REITs

CubeSmart JV With CBRE IM Tests Growth Prospects And Valuation Gap

CubeSmart (NYSE:CUBE) has entered a $250 million joint venture with CBRE Investment Management. The partnership is focused on expanding CubeSmart's presence in high growth self storage markets. The new venture comes as the self storage market shows signs of recovery and renewed investor interest. For investors watching NYSE:CUBE at a share price of $39.66, this move adds a fresh layer to the story. The stock is up 12.0% year to date and has returned 34.6% over 5 years, while 1 year and 3...
NasdaqGM:HRMY
NasdaqGM:HRMYPharmaceuticals

Is Harmony Biosciences (HRMY) Pricing Reflect Recent Share Slump And DCF Upside Potential

If you are wondering whether Harmony Biosciences Holdings is attractively priced or misunderstood by the market, you are not alone. This article will walk through what the current share price really implies. The stock last closed at US$26.87, after declines of 25.4% over the past week, 27.0% over the past month, and 21.4% over the past year. These moves may have changed how investors view both its potential and its risks. Recent news coverage around Harmony Biosciences has focused on the...
NYSE:CBU
NYSE:CBUBanks

Community Financial System Adds Insurance Veteran To Deepen Board Risk Oversight

Community Financial System (NYSE:CBU) has appointed Brenda M. Hall as a new independent director to its Board. Hall previously served as chief operating officer in the insurance industry, with experience in enterprise strategy, risk management, and regulatory oversight. The appointment is intended to deepen the Board’s expertise in governance and oversight for shareholders and other stakeholders. Community Financial System, the parent of Community Bank, operates as a regional financial...
NasdaqGS:CWST
NasdaqGS:CWSTCommercial Services

Casella Waste Systems Pursues Deal Driven Growth As Margins Come Under Strain

Casella Waste Systems (NasdaqGS:CWST) has completed nine acquisitions, adding more than $115 million in annualized revenues. The company outlined an active pipeline of additional deals it aims to pursue in 2026. Management framed the acquisition push as a key lever for scaling operations and driving efficiencies across the business. For investors following NasdaqGS:CWST, this deal streak comes at a time when the stock is trading at $92.71 and has seen a 17.2% decline over the past year,...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Will Fortrea (FTRE) Executive Shifts Refocus Its Clinical Margin Story Or Signal Strategic Drift?

On 17 February 2026, Fortrea Holdings expanded its executive team by dedicating Oren Cohen, MD solely to the chief medical officer role and appointing Scott Dove, PhD as president of Clinical Pharmacology Services, with both serving on the Executive Committee. This leadership reshaping concentrates seasoned medical and early development expertise at the top of the organization, potentially affecting how Fortrea runs trials and manages its clinical pharmacology operations. Next, we’ll examine...
NasdaqGS:SAIA
NasdaqGS:SAIATransportation

Saia Faces Volume Strain As Price Hikes And Investment Hit Returns

Saia (NasdaqGS:SAIA) is facing ongoing sales volume challenges over the last two years and has leaned on price increases to support revenue. At the same time, the company has stepped up investment activity, which has pressured cash flows. Returns on capital have declined, raising questions about whether Saia’s traditional profit drivers are maturing. Saia operates in the less than truckload freight sector, where pricing power and network efficiency matter as much as demand trends. For you...